Beta-blockers in patients with lower MAPs significantly associated with glaucoma
In patients with mean arterial pressure (MAP) < 93 (blood pressure < 120/80), the use of systemic beta-blockers was significantly associated with glaucoma, according to a poster presented at the 2020 AAO Virtual Meeting.
Researchers used data from 4025 respondents of the 2007-2008 National Health and Nutrition Examination Survey (NHANES) to investigate the relationship between self-reported blood pressure medications and glaucoma.
The use of systemic beta-blockers was significantly associated with glaucoma in patients with MAP < 93 (blood pressure < 120/80). In these patients, there was a 4% increase in the odds of having glaucoma. Diabetes and age-related macular degeneration were also significantly associated with glaucoma, whereas high cholesterol or statin use was not, according to the presentation.
Lin WV, et al. Glaucoma, Blood Pressure and Medications: Insights From the National Health and Nutrition Examination Survey (NHANES). Presented at: 2020 AAO Virtual Meeting.
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809